Individuals who regularly use pain reliever aspirin are likely to experience a significant reduction in digestive cancer risk, finds a study involving over 600,000 people. The findings showed that patients who were prescribed aspirin daily showed a 47 per cent reduction in liver and oesophageal cancer incidence. Gastric cancer reduced by 38 per cent, pancreatic …